Cite
OBESITY AND ADVERSE CARDIAC REMODELING IN HFPEF: THE PARAGON-HF TRIAL.
MLA
Wang, Xiaowen, et al. “Obesity and Adverse Cardiac Remodeling in Hfpef: The Paragon-Hf Trial.” Journal of the American College of Cardiology (JACC), vol. 83, no. 13, Apr. 2024, p. 1575. EBSCOhost, https://doi.org/10.1016/S0735-1097(24)03565-4.
APA
Wang, X., Ostrominski, J., Litwin, S. E., Cikes, M., Merkely, B., Kosztin, A., Mullens, W., Inciardi, R. M., Peikert, A., Pabon, M., Hegde, S. M., Skali, H., Shah, A. M., Claggett, B., Packer, M., Pfeffer, M. A., McMurray, J. J. V., & Solomon, S. D. (2024). Obesity and Adverse Cardiac Remodeling in Hfpef: The Paragon-Hf Trial. Journal of the American College of Cardiology (JACC), 83(13), 1575. https://doi.org/10.1016/S0735-1097(24)03565-4
Chicago
Wang, Xiaowen, John Ostrominski, Sheldon E. Litwin, Maja Cikes, Bela Merkely, Annamaria Kosztin, Wilfried Mullens, et al. 2024. “Obesity and Adverse Cardiac Remodeling in Hfpef: The Paragon-Hf Trial.” Journal of the American College of Cardiology (JACC) 83 (13): 1575. doi:10.1016/S0735-1097(24)03565-4.